Clinical Management of Multiple Sclerosis
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 1020
Special Issue Editors
Interests: neurological diseases; multiple sclerosis; stroke; ischemic stroke
Interests: myasthenia gravis; multiple sclerosis; myelin oligodendrocyte glycoprotein antibody disease; myelooptic neuropathy
Special Issue Information
Dear Colleagues,
Recent advances in therapeutic interventions in multiple sclerosis have significantly enhanced disease management and the quality of life for patients. Over the past decade, research has delved into the prevalence and impact of comorbid conditions on disease progression, as well as on the overall welfare of patients with multiple sclerosis. Future perspectives entail the systematic documentation of comorbidities in this population, the exploration of the potential drug interactions with these comorbid conditions, and subsequently the relationship between the presence of comorbid conditions and disability progression. This Special Issue of the Journal of Clinical Medicine welcomes commentaries, original research and reviews focusing on the advances in research, diagnosis monitoring and treatment of multiple sclerosis and other demyelinating disorders. This Special Issue aims to enrich the current literature on the advances in phenotyping people with demyelinating disorders and comorbid conditions, personalised treatment strategies, and the systematic recording of these conditions.
Prof. Dr. Sotirios Giannopoulos
Dr. John S. Tzartos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multiple sclerosis
- comorbidities
- quality of life
- disease modifying treatments
- demyelination disorders
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
